60 Degrees Pharmaceuticals annual revenue
2022
2023
2024
2025
60 Degrees Pharmaceuticals Revenue Growth & History (SXTP)
60 Degrees Pharmaceuticals reported $1.0M in revenue for fiscal 2025, an increase of 65.49% from the previous fiscal year.
View full 60 Degrees Pharmaceuticals company overview60 Degrees Pharmaceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.0M | $397,897 | +65.49% |
| 2024 | 2024-12-31 | $607,574 | $354,001 | +139.61% |
| 2023 | 2023-12-31 | $253,573 | $30,365 | +13.60% |
| 2022 | 2022-12-31 | $223,208 | — | — |
60 Degrees Pharmaceuticals quarterly revenue
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $207,898 | $106,966 | +105.98% |
| Q1 2026 | 2026-03-31 | $162,092 | −$1,460 | −0.89% |
| Q4 2025 | 2025-12-31 | $303,385 | $61,750 | +25.56% |
| Q3 2025 | 2025-09-30 | $437,602 | $302,309 | +223.45% |
| Q2 2025 | 2025-06-30 | $100,932 | −$24,040 | −19.24% |
| Q1 2025 | 2025-03-31 | $163,552 | $57,878 | +54.77% |
| Q4 2024 | 2024-12-31 | $241,635 | $115,954 | +92.26% |
| Q3 2024 | 2024-09-30 | $135,293 | $84,105 | +164.31% |
| Q2 2024 | 2024-06-30 | $124,972 | $65,440 | +109.92% |
| Q1 2024 | 2024-03-31 | $105,674 | $88,502 | +515.39% |
| Q4 2023 | 2023-12-31 | $125,681 | — | — |
| Q3 2023 | 2023-09-30 | $51,188 | −$116,997 | −69.56% |
| Q2 2023 | 2023-06-30 | $59,532 | $14,359 | +31.79% |
| Q1 2023 | 2023-03-31 | $17,172 | — | — |
| Q3 2022 | 2022-09-30 | $168,185 | — | — |
| Q2 2022 | 2022-06-30 | $45,173 | — | — |
60 Degrees Pharmaceuticals revenue growth trends
60 Degrees Pharmaceuticals's latest reported quarter, Q2 2026, generated $207,898 in revenue, an increase of 105.98% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review 60 Degrees Pharmaceuticals source filings ↗